LISA EASTERLING: Open Payments
NPI 1649609397 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 64 payments from 14 companies in 2025. Trend: 2023 $2,015 · 2024 $940 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $240 |
| Novartis Pharmaceuticals Corporation | 14 | $236 |
| Novo Nordisk Inc | 4 | $181 |
| Merck Sharp & Dohme LLC | 10 | $167 |
| PFIZER INC. | 8 | $148 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Boston Scientific Corporation | 2 | $56 |
| AtriCure, Inc. | 2 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: CAMZYOS, LEQVIO, Wegovy, VERQUVO, VYNDAQEL, ELIQUIS, WATCHMAN FLX, SYNERGY ABLATION SYSTEM.
Industry payments across LA — which companies pay providers there.
